BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Amneal Pharmaceuticals received Food and Drug Administration approval for its albuterol sulfate inhalation aerosol to treat bronchospasm in people with reversible obstructive airway disease. The ...
BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (AMRX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s albuterol sulfate ...
Albuterol sulfate inhalation aerosol is indicated for the treatment or prevention of bronchospasm in adults and children 12 years of age and older with reversible obstructive airway disease. Kone ...
Mild asthma could be better treated with the recent approval of the combination of albuterol/budesonide. The recent approval of albuterol/budesonide could change the way that mild asthma is treated in ...
Ritedose Pharmaceuticals has received the Food and Drug Administration’s approval for manufacturing and distributing generic albuterol sulfate inhalation solution, 0.5% (2.5 mg/0.5 ml). "Driven by the ...
As-needed use of albuterol–budesonide has been shown to result in a significantly lower risk of severe asthma exacerbation than as-needed use of albuterol alone among patients with moderate-to-severe ...
For many years, the standard treatment for asthma was an inhaler with a medication called albuterol. Only if that wasn’t enough would additional medicines be added. If symptoms became especially bad, ...
On June 10, 2024, Judge Stanley R. Chesler of the United States District Court for the District of New Jersey granted the Amneal defendants’ motion for partial judgment on their counterclaims in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results